The directors of Queensland Bauxite Ltd (ASX:QBL) are excited to inform our shareholders that completion of the acquisition of 55% of MCL has occurred today with the issue of 49 million shares in QBL to the shareholders of MCL.
Over the past 18 months Australian Bauxite Ltd (ASX:ABX) has increased its capacity to supply cement-grade bauxite whilst remaining ready to sell metallurgical grade bauxite when prices improve.
Current trends in the metallurgical grade Chinese markets are encouraging and Australian Bauxite Ltd (ASX:ABX) is beginning to engage with potential customer refineries - but current prices still need to rise a bit yet.
As the directors of Medical Cannabis Limited (MCL) are drafting a prospectus for an independent ASX listing of MCL, the Board of MCL in conjunction with the QBL (ASX:QBL) Board, have decided that the MCL Initial Public Offering (IPO) will be giving Queensland Bauxite shareholders preference to take up shares in the anticipated MCL Listing on ASX.
Australian Bauxite Ltd (ASX:ABX) has received a letter of intent for a significant shipment of cement grade bauxite from its Bald Hill Bauxite Project near Campbell Town, northern Tasmania.
Andrew Kavasilas, Technical Director of Medical Cannabis Limited (MCL), has been interviewed by 2Ser 107.3 in relation to the work that he has been doing with Medical Cannabis Limited and Vitahemp, and in preparation for the upcoming Hemp Health and Innovation Expo, Australia's largest Cannabis Expo. Andrew also discussed general information on the industry and Cannabis.
On the 10th March 2017, Andrew Kavasilas, Director of Medical Cannabis Limited received permission from the Department of Primary Industries to start an indoor grow project of low THC Cannabis, in preparation for the Hemp & Health Innovation Expo in May as a continuation of the Company's existing Cannabis growing and research project.
